Check out the chairmans addresses. Check out the progress. No false promises!!!! The first license was originally hoped for by mid last year. That time frame was obviously far too optimistic, but at least it is now happening.
NAS listing.
GTG is pursuing a responsible blend of commercial activities with R&D, nothing to suggest otherwise.
Plenty of blue sky for the medium to long term holders.
Check out Dr Jacobson.
The market likes GTG (the market has punished other BioTechs).
GTG Price at posting:
0.0¢ Sentiment: None Disclosure: Held
